Literature DB >> 1500507

Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

L G Wayne1, D Hollander, B Anderson, H A Sramek, C M Vadheim, J I Rotter.   

Abstract

Sera from patients with Crohn's disease, their relatives, their spouses, and unrelated healthy controls were assayed by enzyme-linked immunosorbent assay for immunoglobulin G (IgG) and IgA antibodies to Mycobacterium tuberculosis, M. avium, and M. gordonae. The patients had significantly higher IgA responses to mycobacterial antigens than did either their relatives or the controls. On the other hand, both the patients and their relatives had significantly higher IgG responses against these antigens than did the controls. The elevated IgA response was more pronounced against isopentanol-extracted whole bacterial cells than it was against soluble protein extracts, and it appeared to be directed against fixed surface antigens that lie under the loosely bound peptidoglycolipid or glycolipid antigens of mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500507      PMCID: PMC265433          DOI: 10.1128/jcm.30.8.2013-2018.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis.

Authors:  L G Wayne; H A Sramek
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

Review 2.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

3.  Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

Authors:  H McKenzie; J Main; C R Pennington; D Parratt
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

4.  Serum antibodies to mycobacterial antigens in active Crohn's disease.

Authors:  K Kobayashi; W R Brown; P J Brennan; M J Blaser
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

5.  Extraction of detergents from hydrophobic proteins with isopentanol: application to electrophoretic analysis of photosynthetic bacterial hydrophobic proteins.

Authors:  J R Salcedo; R S Hernández; H Célis
Journal:  Anal Biochem       Date:  1983-07-15       Impact factor: 3.365

6.  Peptidoglycolipid nature of the superficial cell wall sheath of smooth-colony-forming mycobacteria.

Authors:  W W Barrow; B P Ullom; P J Brennan
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

7.  Intestinal permeability in patients with Crohn's disease and their healthy relatives.

Authors:  K D Katz; D Hollander; C M Vadheim; C McElree; T Delahunty; V D Dadufalza; P Krugliak; J I Rotter
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

8.  Investigation of association of mycobacteria with inflammatory bowel disease by nucleic acid hybridization.

Authors:  H H Yoshimura; D Y Graham; M K Estes; R S Merkal
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

9.  A new hypothesis for the aetiology of Crohn's disease--evidence from lipid metabolism and intestinal tuberculosis.

Authors:  W E Roediger
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

10.  Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease.

Authors:  J M Grange; J Gibson; E Nassau; T Kardjito
Journal:  Tubercle       Date:  1980-09
View more
  9 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.

Authors:  B Wei; H Dalwadi; L K Gordon; C Landers; D Bruckner; S R Targan; J Braun
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 3.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.

Authors:  O Cohavy; G Harth; M Horwitz; M Eggena; C Landers; C Sutton; S R Targan; J Braun
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Specific antibody response to oligomannosidic epitopes in Crohn's disease.

Authors:  B Sendid; J F Colombel; P M Jacquinot; C Faille; J Fruit; A Cortot; D Lucidarme; D Camus; D Poulain
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

6.  Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis.

Authors:  P Vannuffel; C Dieterich; B Naerhuyzen; P Gilot; M Coene; R Fiasse; C Cocito
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

7.  Evaluation of an immunochromatographic test for the diagnosis of pulmonary tuberculosis in Madagascar.

Authors:  Al-Habib O Said Toihir; Vincent Richard; Vaomalala Raharimanga; Samuel H Andrianarisoa; Gabriel M Ranjalahy; Herimanana Ramarokoto; Voahangy Rasolofo
Journal:  BMC Res Notes       Date:  2011-10-12

Review 8.  Serological markers of inflammatory bowel disease.

Authors:  Andrea Tesija Kuna
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

9.  Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease.

Authors:  Y Liu; H J van Kruiningen; A B West; R W Cartun; A Cortot; J F Colombel
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.